Response to ‘Pervasive Sequence Patents Cover the Entire Human Genome’

In a widely reported article by Jeffrey Rosenfeld and Christopher Mason published in Genome Medicine, significant misstatements were made, because the authors did not sufficiently review the claims – which define the legal scope of a patent – in the patents they analyzed. Specifically, the authors do not provide an adequate basis for their assertion that 41% of the genes in the human genome have been claimed

MoreLess

Year of publication:	2014
Authors:	Tu, S. Sean ; Holman, Christopher M. ; Mossoff, Adam ; Sichelman, Ted M. ; Risch, Michael ; Contreras, Jorge L. ; Heled, Yaniv ; Dolin, Gregory ; Petherbridge, Lee
Publisher:	[S.l.] : SSRN

freely available

Full text |

More access options

Check Google Scholar

In German libraries (KVK)

I need help

Extent:	1 Online-Ressource (4 p)
Type of publication:	Book / Working Paper
Language:	English
Notes:	In: Genome Medicine, Vol. 6, No. 14, 2014 Nach Informationen von SSRN wurde die ursprüngliche Fassung des Dokuments February 27, 2014 erstellt
Classification:	O34 - Intellectual Property Rights: National and International Issues
Source:	ECONIS - Online Catalogue of the ZBW

Persistent link: https://www.econbiz.de/10014037538